Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

To medicate or not to medicate, when diagnosis is in question: decision-making in first episode psychosis.

Malhi G, Adams D, Moss B, Walter G.

Australas Psychiatry. 2010 Jun;18(3):230-7. doi: 10.3109/10398560903358846.

PMID:
20158435
2.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

PMID:
14640142
3.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
4.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
5.

Clinical profiles, scope and general findings of the Western Sydney First Episode Psychosis Project.

Harris A, Brennan J, Anderson J, Taylor A, Sanbrook M, Fitzgerald D, Lucas S, Redoblado-Hodge A, Gomes L, Gordon E.

Aust N Z J Psychiatry. 2005 Jan-Feb;39(1-2):36-43.

PMID:
15660704
6.

Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.

Chan KK, Chin QP, Tang JY, Longenecker J, Hui CL, Chiu CP, Lam MM, Wong GH, Chen EY.

Early Interv Psychiatry. 2011 Nov;5(4):324-34. doi: 10.1111/j.1751-7893.2011.00268.x. Epub 2011 Apr 26.

PMID:
21521490
7.

[Therapeutic strategies in the first psychotic episode].

Douki S, Taktak MJ, Ben Zineb S, Cheour M.

Encephale. 1999 Nov;25 Spec No 3:44-51. Review. French.

PMID:
10598294
8.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
9.

A review of second-generation antipsychotic discontinuation in first-episode psychosis.

Miller BJ.

J Psychiatr Pract. 2008 Sep;14(5):289-300. doi: 10.1097/01.pra.0000336756.65308.83. Review.

PMID:
18832960
10.

[Atypical antipsychotics in first-episode psychosis: a review].

Rotgé JY, Aouizerate B, Tignol J.

Encephale. 2008 Apr;34(2):194-204. doi: 10.1016/j.encep.2007.07.003. Epub 2007 Oct 24. Review. French.

PMID:
18597729
11.

Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.

Berger GE, Proffitt TM, McConchie M, Yuen H, Wood SJ, Amminger GP, Brewer W, McGorry PD.

J Clin Psychiatry. 2007 Dec;68(12):1867-75.

PMID:
18162017
12.

First-episode psychosis: a window of opportunity for best practices.

Buckley PF, Correll CU, Miller AL.

CNS Spectr. 2007 Sep;12(9 Suppl 15):1-12; discussion 13-4; quiz 15-6.

PMID:
17805219
13.

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J.

Eur Neuropsychopharmacol. 2009 Jul;19(7):520-32. doi: 10.1016/j.euroneuro.2009.04.003. Epub 2009 May 2.

PMID:
19411165
14.

Familial psychopathology in the First Episode Psychosis Outcome Study.

Morley KI, Cotton SM, Conus P, Lambert M, Schimmelmann BG, McGorry PD, Foley DL.

Aust N Z J Psychiatry. 2008 Jul;42(7):617-26. doi: 10.1080/00048670802119754.

PMID:
18612865
15.

[The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].

Santiago-Delefosse M, Cahen F, Coeffin-Driol C.

Encephale. 2003 Jul-Aug;29(4 Pt 1):293-305. French.

PMID:
14615699
16.

Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.

Arendt M, Mortensen PB, Rosenberg R, Pedersen CB, Waltoft BL.

Arch Gen Psychiatry. 2008 Nov;65(11):1269-74. doi: 10.1001/archpsyc.65.11.1269.

PMID:
18981338
17.

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Bret P, Bret MC, Queuille E.

Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. French.

PMID:
19393381
18.

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.

Arch Gen Psychiatry. 2006 Feb;63(2):139-49.

PMID:
16461856
19.

Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment.

Hamann J, Mendel RT, Fink B, Pfeiffer H, Cohen R, Kissling W.

J Nerv Ment Dis. 2008 Apr;196(4):329-32. doi: 10.1097/NMD.0b013e31816a62a0.

PMID:
18414128
20.

First episode psychosis and the trail to secondary care: help-seeking and health-system delays.

O'Callaghan E, Turner N, Renwick L, Jackson D, Sutton M, Foley SD, McWilliams S, Behan C, Fetherstone A, Kinsella A.

Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):381-91. doi: 10.1007/s00127-009-0081-x. Epub 2009 Jul 4.

PMID:
19578801
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk